§ 13F · FUND PROFILE
VR ADVISER, LLC.
AUM · $1.8B (13F)Positions · 33Turnover · n/a · Q2Filed · Aug 14, 2026
CONCENTRATION
n/a
Top 10 holdings
NEW BUYS
0
+$38M deployed
EXITS
0
No exits
SECTOR SHIFT
n/a
No prior quarter data
§ 01 · TOP HOLDINGS
The book · Q2 2026
FILED AUG 14, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q2 |
|---|---|---|---|---|---|---|
| 1 | APGE | APOGEE THERAPEUTICS INC | 8.49M | $1.1B | 34.2% | ±0% |
| 2 | ORKA | ORUKA THERAPEUTICS INC | 4.15M | $395M | 12.0% | ±0% |
| 3 | ERAS | ERASCA INC | 17.89M | $328M | 9.9% | +9% |
| 4 | SYRE | SPYRE THERAPEUTICS INC | 2.99M | $265M | 8.0% | −19% |
| 5 | DNTH | DIANTHUS THERAPEUTICS INC | 1.18M | $115M | 3.5% | ±0% |
| 6 | OCUL | OCULAR THERAPEUTIX INC | 10.35M | $102M | 3.1% | ±0% |
| 7 | DMRA | DAMORA THERAPEUTICS INC | 3.60M | $94M | 2.8% | ±0% |
| 8 | SVRA | SAVARA INC | 14.75M | $91M | 2.8% | +7% |
| 9 | JBIO | JADE BIOSCIENCES INC | 3.22M | $72M | 2.2% | ±0% |
| 10 | COGT | COGENT BIOSCIENCES INC | 1.64M | $64M | 1.9% | −18% |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE VR SIGNAL
AC read
VR ADVISER, LLC is a Other fund managing $1.8 billion in assets. The fund runs a portfolio of 33 positions.
Read the full dossier →